Is research into orphan diseases on the rise?

Who should pay for the disposal of unused medicines? Legal tussles continue over ‘drug takeback’ law in Californian county.

An ambitious UK sequencing project aims to learn more about patients with cancer and rare diseases

EMA’s pilot project continues. Is the future of regulation adaptive?

Are vaccines set for a makeover? Two studies from researchers in Massachusetts demonstrate the new approaches that R&D scientists are taking.

A group of researchers have used supercomputers to link proteins to drug side effects.

Pathways designed to bring medicines to market faster in Europe are not delivering the goods

What is an endolysin? We spoke with Bjorn Herpers from the Regional Public Health Laboratory Kennemerland, Haarlem, in the Netherlands to find out.

Could medicines be made more effective with better timing?

Will FDA fast review and voucher incentives make a difference?